Document is current
Any future updates will be listed below
-
Authors
Panchenko, Elizaveta
Kropacheva, Ekaterina
Dobrovolsky, Anatoly
Titaeva, Elena
Zemlyanskaya, Oksana
Trofimov, Dmitry
Galkina, Irina
Lifshits, Galina
Vereina, Natalya
Sinitsin, Sergey
Vorobyeva, Nadezda
Grehova, Lyudmila
Zateyshchikov, Dmitry http://orcid.org/0000-0001-7065-2045
Zotova, Irina
Vavilova, Tatyana
Sirotkina, Olga
Grontkovskaya, Alevtina http://orcid.org/0000-0002-3788-4028
- License Information
-
More Information
Article History
Received: 10 May 2019
Revised: 22 January 2020
Accepted: 27 January 2020
First Online: 6 February 2020
Compliance with ethical standards
:
: EP reports personal fees and nonfinancial support from Takeda, Pfizer, Boehringer Ingelheim, and Bayer during the conduct of the study; AD reports personal fees and nonfinancial support from Takeda, Instrumentation Laboratory, Diagnostica Stago during the conduct of the study; NV reports personal fees from Bayer, Pfizer, and Takeda, outside the submitted work during the conduct of the study; LG reports personal fees and nonfinancial support from Takeda, personal fees and nonfinancial support from Bayer, personal fees from Pfizer, during the conduct of the study; DZ reports personal fees and nonfinancial support from Takeda, AstraZeneca, Boehringer Ingelheim, and Bayer during the conduct of the study; IZ reports personal fees from Takeda, Pfizer, Boehringer Ingelheim, and Bayer during the conduct of the study; TV reports personal fees and nonfinancial support from Takeda, Pfizer, Boehringer Ingelheim, personal fees and Bayer during the conduct of the study; EK has nothing to disclose; ET has nothing to disclose; OZ has nothing to disclose; DT and IG are employees of DNA-Technology JSC, Moscow; GL has nothing to disclose; SS has nothing to disclose; NV has nothing to disclose; OS has nothing to disclose; AG has nothing to disclose.
